Celldex Therapeutics, Inc. (CLDX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 41.24 |
| Open | 41.50 |
| Bid | 41.80 x 100 |
| Ask | 41.91 x 100 |
| Day's Range | 41.50 - 43.19 |
| 52 Week Range | 22.11 - 53.18 |
| Volume | |
| Avg. Volume | 728,671 |
| Market Cap | 2.774B |
| Beta (5Y Monthly) | 1.56 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
Celldex Therapeutics, Inc. (CLDX): Short Seller Sentiment is Bearish on This Cancer Stock
We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. In this article, we are going to take a look at where Celldex Therapeutics, Inc. (NASDAQ:CLDX) stands against the other cancer stocks. Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one […]
- Simply Wall St.
Celldex Therapeutics Second Quarter 2024 Earnings: Beats Expectations
Celldex Therapeutics ( NASDAQ:CLDX ) Second Quarter 2024 Results Key Financial Results Net loss: US$35.8m (loss widened...
- Zacks
Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates
Celldex (CLDX) delivered earnings and revenue surprises of 8.47% and 121.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.